Physician profile
Michael C Yang
NPI 1699336974
$3,145.86
in general payments reported to CMS, 2019-2025
11 companies · $533 in 2025
The $533 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $93.56 · 2022: $457 · 2023: $1,505 · 2024: $558 · 2025: $533.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,373 · Entertainment: $223.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,372.88 |
| Entertainment | $222.75 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,853.84 | 2021-2025 | Hydrus Microstent, Clareon, Rocklatan |
| Acist Medical Systems, INC. | $494.86 | 2023-2024 | |
| Nova Eye, INC. | $312.46 | 2023-2025 | |
| Sight Sciences, INC. | $227.68 | 2024-2025 | Omni Surgical System |
| Abbvie INC. | $76.09 | 2024-2025 | |
| Carl Zeiss Meditec USA, INC. | $47.24 | 2023 | Artevo 800 |
| Rxsight INC | $40.31 | 2024-2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Light Adjustable Lens (Lal) |
| Teleflex LLC | $30.23 | 2023 | Turnpike |
| Mallinckrodt Hospital Products INC. | $24.44 | 2025 | Acthar |
| Thea Pharma INC. | $21.67 | 2025 | Iyuzeh |
| Genentech USA, INC. | $17.04 | 2025 | Vabysmo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.